PULMONX CORPORATION Financing Cash Flow
PULMONX CORPORATION (LUNG) reported Financing Cash Flow of $1.51 million for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-08-04.
Financial Statements › Cash Flow › Financing Activities
us-gaap:NetCashProvidedByUsedInFinancingActivities · last filed 2026-08-04
- PULMONX CORPORATION net cash provided by (used in) financing activities for the quarter ending 2026-06-30 was -$513.00K.
- PULMONX CORPORATION net cash provided by (used in) financing activities for the quarter ending 2026-03-31 was $2.03M, a 205.12% increase year-over-year.
- PULMONX CORPORATION net cash provided by (used in) financing activities for the quarter ending 2025-12-31 was $55.00K, a 11.29% decline year-over-year.
- PULMONX CORPORATION net cash provided by (used in) financing activities for the quarter ending 2025-09-30 was $181.00K, a 60.57% decline year-over-year.
- PULMONX CORPORATION net cash provided by (used in) financing activities for fiscal 2025 was $833.00K, a 38.88% decline from fiscal 2024.
- PULMONX CORPORATION net cash provided by (used in) financing activities for fiscal 2024 was $1.36M, a 93.63% decline from fiscal 2023.
- PULMONX CORPORATION net cash provided by (used in) financing activities for fiscal 2023 was $21.40M, a 784.66% increase from fiscal 2022.
- PULMONX CORPORATION net cash provided by (used in) financing activities for fiscal 2022 was $2.42M, a 45.71% decline from fiscal 2021.
| Period end | Net Cash Provided by (Used in) Financing Activities 3 month | Net Cash Provided by (Used in) Financing Activities 6 month | Net Cash Provided by (Used in) Financing Activities 9 month | Net Cash Provided by (Used in) Financing Activities 12 month |
|---|---|---|---|---|
| 2026-06-30 | -$513.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-04 | $1.51M 10-Q · filed 2026-08-04 | $1.57M derived: sum of 3 quarters · filed 2026-08-04 | $1.75M derived: sum of 4 quarters · filed 2026-08-04 |
| 2026-03-31 | $2.03M 10-Q · filed 2026-05-04 | $2.08M derived: sum of 2 quarters · filed 2026-05-04 | $2.26M derived: sum of 3 quarters · filed 2026-05-04 | $2.19M derived: sum of 4 quarters · filed 2026-08-04 |
| 2025-12-31 | $55.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-10 | $236.00K derived: sum of 2 quarters · filed 2026-03-10 | $169.00K derived: sum of 3 quarters · filed 2026-08-04 | $833.00K 10-K · filed 2026-03-10 |
| 2025-09-30 | $181.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-12 | $114.00K derived: sum of 2 quarters · filed 2026-08-04 | $778.00K 10-Q · filed 2025-11-12 | $840.00K derived: sum of 4 quarters · filed 2026-08-04 |
| 2025-06-30 | -$67.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-04 | $597.00K 10-Q · filed 2026-08-04 | $659.00K derived: sum of 3 quarters · filed 2026-08-04 | $1.12M derived: sum of 4 quarters · filed 2026-08-04 |
| 2025-03-31 | $664.00K 10-Q · filed 2026-05-04 | $726.00K derived: sum of 2 quarters · filed 2026-05-04 | $1.19M derived: sum of 3 quarters · filed 2026-05-04 | $1.16M derived: sum of 4 quarters · filed 2026-05-04 |
| 2024-12-31 | $62.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-10 | $521.00K derived: sum of 2 quarters · filed 2026-03-10 | $499.00K derived: sum of 3 quarters · filed 2026-03-10 | $1.36M 10-K · filed 2026-03-10 |
| 2024-09-30 | $459.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-12 | $437.00K derived: sum of 2 quarters · filed 2025-11-12 | $1.30M 10-Q · filed 2025-11-12 | $1.32M derived: sum of 4 quarters · filed 2025-11-12 |
| 2024-06-30 | -$22.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2025-08-01 | $842.00K 10-Q · filed 2025-08-01 | $859.00K derived: sum of 3 quarters · filed 2025-08-01 | $1.43M derived: sum of 4 quarters · filed 2025-08-01 |
| 2024-03-31 | $864.00K 10-Q · filed 2025-05-02 | $881.00K derived: sum of 2 quarters · filed 2025-05-02 | $1.45M derived: sum of 3 quarters · filed 2025-05-02 | $1.54M derived: sum of 4 quarters · filed 2025-05-02 |
| 2023-12-31 | $17.00K derived: 10-K 12 month − 10-Q 9 month · filed 2025-02-25 | $588.00K derived: sum of 2 quarters · filed 2025-02-25 | $680.00K derived: sum of 3 quarters · filed 2025-02-25 | $21.40M 10-K · filed 2025-02-25 |
| 2023-09-30 | $571.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-01 | $663.00K derived: sum of 2 quarters · filed 2024-11-01 | $21.38M 10-Q · filed 2024-11-01 | $21.45M derived: sum of 4 quarters · filed 2024-11-01 |
| 2023-06-30 | $92.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2024-08-02 | $20.81M 10-Q · filed 2024-08-02 | $20.88M derived: sum of 3 quarters · filed 2024-08-02 | $21.79M derived: sum of 4 quarters · filed 2024-08-02 |
| 2023-03-31 | $20.72M 10-Q · filed 2024-05-03 | $20.79M derived: sum of 2 quarters · filed 2024-05-03 | $21.69M derived: sum of 3 quarters · filed 2024-05-03 | $21.82M derived: sum of 4 quarters · filed 2024-05-03 |
| 2022-12-31 | $67.00K derived: 10-K 12 month − 10-Q 9 month · filed 2024-02-27 | $973.00K derived: sum of 2 quarters · filed 2024-02-27 | $1.10M derived: sum of 3 quarters · filed 2024-02-27 | $2.42M 10-K · filed 2024-02-27 |
| 2022-09-30 | $906.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-03 | $1.04M derived: sum of 2 quarters · filed 2023-11-03 | $2.35M 10-Q · filed 2023-11-03 | $2.50M derived: sum of 4 quarters · filed 2023-11-03 |
| 2022-06-30 | $131.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-04 | $1.45M 10-Q · filed 2023-08-04 | $1.60M derived: sum of 3 quarters · filed 2023-08-04 | $2.60M derived: sum of 4 quarters · filed 2023-08-04 |
| 2022-03-31 | $1.31M 10-Q · filed 2023-05-08 | $1.47M derived: sum of 2 quarters · filed 2023-05-08 | $2.46M derived: sum of 3 quarters · filed 2023-05-08 | $5.76M derived: sum of 4 quarters · filed 2023-05-08 |
| 2021-12-31 | $150.00K derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-01 | $1.15M derived: sum of 2 quarters · filed 2023-03-01 | $4.44M derived: sum of 3 quarters · filed 2023-03-01 | $4.46M 10-K · filed 2023-03-01 |
| 2021-09-30 | $1.00M derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-08 | $4.29M derived: sum of 2 quarters · filed 2022-11-08 | $4.31M 10-Q · filed 2022-11-08 | $204.07M derived: sum of 4 quarters · filed 2022-11-08 |
| 2021-06-30 | $3.29M derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-08 | $3.31M 10-Q · filed 2022-08-08 | $203.07M derived: sum of 3 quarters · filed 2022-08-08 | $205.43M derived: sum of 4 quarters · filed 2022-08-08 |
| 2021-03-31 | $13.00K 10-Q · filed 2022-05-09 | $199.78M derived: sum of 2 quarters · filed 2022-05-09 | $202.14M derived: sum of 3 quarters · filed 2022-05-09 | $233.54M derived: sum of 4 quarters · filed 2022-05-09 |
| 2020-12-31 | $199.76M derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-01 | $202.12M derived: sum of 2 quarters · filed 2022-03-01 | $233.52M derived: sum of 3 quarters · filed 2022-03-01 | $234.83M 10-K · filed 2022-03-01 |
| 2020-09-30 | $2.36M derived: 10-Q 9 month − 10-Q 6 month · filed 2021-11-09 | $33.76M derived: sum of 2 quarters · filed 2021-11-09 | $35.07M 10-Q · filed 2021-11-09 | $34.65M derived: sum of 4 quarters · filed 2021-11-09 |
| 2020-06-30 | $31.40M derived: 10-Q 6 month − 10-Q 3 month · filed 2021-08-10 | $32.71M 10-Q · filed 2021-08-10 | $32.29M derived: sum of 3 quarters · filed 2021-08-10 | |
| 2020-03-31 | $1.31M 10-Q · filed 2021-05-12 | $890.00K derived: sum of 2 quarters · filed 2021-05-12 | ||
| 2019-12-31 | -$418.00K derived: 10-K 12 month − 10-Q 9 month · filed 2021-03-15 | $45.62M 10-K · filed 2021-03-15 | ||
| 2019-09-30 | $46.04M 10-Q · filed 2020-11-13 | |||
| 2018-12-31 | $12.11M 10-K · filed 2021-03-15 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| SkinHealth Systems Inc. (SKIN) | United States | $0.086B | -3.17 |
| LENSAR, Inc. (LNSR) | United States | $0.087B | 2.02 |
| RenovoRx, Inc. (RNXT) | United States | $0.076B | -3.62 |
| Microbot Medical Inc. (MBOT) | $0.089B | -7.97 | |
| FRACTYL HEALTH, INC. (GUTS) | United States | $0.075B | -1.18 |
| CVRx, Inc. (CVRX) | United States | $0.067B | -2.62 |
| DarioHealth Corp. (DRIO) | $0.066B | -1.39 | |
| TELA Bio, Inc. (TELA) | United States | $0.057B | -0.82 |
| Xtant Medical Holdings, Inc. (XTNT) | United States | $0.053B | |
| Spectral AI, Inc. (MDAI) | United States | $0.052B |